\-\ Texto\\:\\ \ \(0\)\
\-\ subtle\\ mass\\ palpable\\ at\\ 3\\ o\\'clock\\.\\ no\\ nipple\\ discharge\\ or\\ skin\\ changes\\.\ \(0\)\
\-\ excision\\.\\ confirms\\ papilloma\\.\\ \\ atypical\\ ductal\\ hyperplasia\\ is\\ also\\ noted\\.\ \(0\)\
\-\ two\\ very\\ small\\ and\\ new\\ clusters\\ of\\ microcalcifications\\ was\\ identified\\ in\\ the\\ left\\ upper\\ outer\\ breast\\ and\\ subareolar\\ left\\ breast\\ on\\ the\\ screening\\ mammogram\\ and\\ confirmed\\ with\\ magnification\\.\\ \\ the\\ calcifications\\ are\\ not\\ easily\\ seen\\,\\ therefore\\ the\\ mammogram\\ is\\ not\\ included\\ for\\ viewing\\.\\ \\ the\\ area\\ of\\ calcifications\\ and\\ palpable\\ mass\\ correlate\\.\ \(0\)\
\-\ sonographic\\ evaluation\\ of\\ the\\ palpable\\ mass\\ reveals\\ a\\ well\\ circumscribed\\ round\\ hypoechoic\\ mass\\.\\ \\ \ \(0\)\
\-\ core\\ needle\\ biopsy\\ was\\ performed\\ immediately\\.\ \(0\)\
\-\ intraductal\\ papilloma\\ of\\ the\\ breast\ \(0\)\
\-\ fibroadenoma\ \(22\)\
\-\ breast\\ neoplasm\\,\\ no\\ type\\ is\\ excluded\ \(0\)\
\-\ papilloma\ \(115\)\
\-\ subtle\\ left\\ upper\\ outer\\ quadrant\\ mass\\ palpated\\ by\\ the\\ examining\\ clinician\\ at\\ the\\ annual\\ physical\\.\\ \\ the\\ patient\\ is\\ otherwise\\ asymptomatic\\ with\\ respect\\ to\\ the\\ breasts\\.\ \(0\)\
\-\ papilloma\\ is\\ usually\\ excised\\ since\\ a\\ papillary\\ neoplasm\\ cannot\\ be\\ excluded\\.\\ \\ the\\ distinction\\ between\\ benign\\ papilloma\\ and\\ papillary\\ carcinoma\\ is\\ often\\ difficult\\ for\\ the\\ pathologist\\.\\ \\ other\\ new\\ areas\\ of\\ calcification\\ were\\ identified\\ in\\ this\\ patient\\,\\ and\\ although\\ they\\ may\\ be\\ related\\ to\\ fibrocystic\\ change\\,\\ treatment\\ determinations\\ are\\ not\\ straightforward\\.\\ since\\ atypical\\ ductal\\ hyperplasia\\ is\\ noted\\ in\\ the\\ excised\\ specimen\\,\\ follow\\ up\\ mammography\\ is\\ necessary\\ to\\ carefully\\ assess\\ the\\ operative\\ bed\\ for\\ absence\\ of\\ the\\ calcifications\\ which\\ are\\ held\\ to\\ be\\ associated\\ with\\ this\\ papilloma\\ and\\ to\\ scrutnize\\ the\\ remainder\\ of\\ the\\ breasts\\.\\ \\ atypical\\ ductal\\ hyperplasia\\ is\\ associated\\ with\\ a\\ higher\\ incidence\\ of\\ breast\\ carcinoma\\.\ \(0\)\
\-\ core\\ bipsy\\ is\\ performed\\ as\\ an\\ accurate\\ and\\ rapid\\ means\\ to\\ confirm\\ strong\\ suspicions\\ of\\ either\\ a\\ benign\\ or\\ malignant\\ mass\\.\\ this\\ minimally\\ invasive\\ procedure\\ can\\ provide\\ the\\ information\\ necessary\\ to\\ avoid\\ an\\ \\"extra\\"\\ excisional\\ procedure\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ papilloma\\:\\ 0\\.08733009858137201\ \(0\)\
\-\ breast\\:\\ 0\\.053433185488653424\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.04281710072520413\ \(0\)\
\-\ ductal\\:\\ 0\\.04096298319848595\ \(0\)\
\-\ atypical\\:\\ 0\\.03766302341298259\ \(0\)\
\-\ excised\\:\\ 0\\.03648495742021256\ \(0\)\
\-\ breasts\\:\\ 0\\.035858697622714146\ \(0\)\
\-\ calcifications\\:\\ 0\\.032310139877621206\ \(0\)\
\-\ core\\:\\ 0\\.0321219049495646\ \(0\)\
\-\ excluded\\:\\ 0\\.03136178767416998\ \(0\)\
\-\ palpable\\:\\ 0\\.030799536026438545\ \(0\)\
\-\ outer\\:\\ 0\\.030771880033562325\ \(0\)\
\-\ mammogram\\:\\ 0\\.030229217608656992\ \(0\)\
\-\ determinations\\:\\ 0\\.02988311330158135\ \(0\)\
\-\ scrutnize\\:\\ 0\\.02988311330158135\ \(0\)\
\-\ bipsy\\:\\ 0\\.02988311330158135\ \(0\)\
\-\ papillary\\:\\ 0\\.0294114007422935\ \(0\)\
\-\ subtle\\:\\ 0\\.026611317259286404\ \(0\)\
\-\ suspicions\\:\\ 0\\.02615900384846911\ \(0\)\
\-\ necessary\\:\\ 0\\.025661562729315676\ \(0\)\
\-\ straightforward\\:\\ 0\\.025183810382530872\ \(0\)\
\-\ pathologist\\:\\ 0\\.024427391564516603\ \(0\)\
\-\ procedure\\:\\ 0\\.02426492516024779\ \(0\)\
\-\ mass\\:\\ 0\\.024172088276899616\ \(0\)\
\-\ subareolar\\:\\ 0\\.02328680771156334\ \(0\)\
\-\ viewing\\:\\ 0\\.022434894395356876\ \(0\)\
\-\ held\\:\\ 0\\.022434894395356876\ \(0\)\
\-\ clusters\\:\\ 0\\.022077740104991365\ \(0\)\
\-\ examining\\:\\ 0\\.022077740104991365\ \(0\)\
\-\ distinction\\:\\ 0\\.021459700929418634\ \(0\)\
\-\ fibrocystic\\:\\ 0\\.021459700929418634\ \(0\)\
\-\ since\\:\\ 0\\.02127976014710655\ \(0\)\
\-\ o\\'clock\\:\\ 0\\.0209371562520381\ \(0\)\
\-\ magnification\\:\\ 0\\.0209371562520381\ \(0\)\
\-\ identified\\:\\ 0\\.020701471465669974\ \(0\)\
\-\ carefully\\:\\ 0\\.02027900027088231\ \(0\)\
\-\ new\\:\\ 0\\.020188393063054633\ \(0\)\
\-\ benign\\:\\ 0\\.019993561810394585\ \(0\)\
\-\ neoplasm\\:\\ 0\\.019729875090928325\ \(0\)\
\-\ excisional\\:\\ 0\\.019728088645466126\ \(0\)\
\-\ microcalcifications\\:\\ 0\\.019405003290197228\ \(0\)\
\-\ intraductal\\:\\ 0\\.019254319349279146\ \(0\)\
\-\ is\\:\\ 0\\.019060704352024598\ \(0\)\
\-\ accurate\\:\\ 0\\.01883871825744073\ \(0\)\
\-\ clinician\\:\\ 0\\.018587504792512862\ \(0\)\
\-\ respect\\:\\ 0\\.018468551166033978\ \(0\)\
\-\ fibroadenoma\\:\\ 0\\.018353630651879126\ \(0\)\
\-\ means\\:\\ 0\\.018353630651879126\ \(0\)\
\-\ extra\\:\\ 0\\.018134856003955157\ \(0\)\
\-\ correlate\\:\\ 0\\.018030545296610228\ \(0\)\
\-\ palpated\\:\\ 0\\.017552312760135975\ \(0\)\
\-\ specimen\\:\\ 0\\.017378437185940888\ \(0\)\
\-\ nipple\\:\\ 0\\.017213046798925862\ \(0\)\
\-\ mammography\\:\\ 0\\.01683176549917437\ \(0\)\
\-\ bed\\:\\ 0\\.01683176549917437\ \(0\)\
\-\ strong\\:\\ 0\\.01683176549917437\ \(0\)\
\-\ avoid\\:\\ 0\\.01676039801036816\ \(0\)\
\-\ not\\:\\ 0\\.01674330402361946\ \(0\)\
\-\ carcinoma\\:\\ 0\\.016419848610277062\ \(0\)\
\-\ provide\\:\\ 0\\.016237853332987624\ \(0\)\
\-\ performed\\:\\ 0\\.01615307343204962\ \(0\)\
\-\ easily\\:\\ 0\\.01600397919235389\ \(0\)\
\-\ information\\:\\ 0\\.01578520454442992\ \(0\)\
\-\ operative\\:\\ 0\\.015629917981611976\ \(0\)\
\-\ confirms\\:\\ 0\\.015385940016781162\ \(0\)\
\-\ minimally\\:\\ 0\\.015071425666099921\ \(0\)\
\-\ needle\\:\\ 0\\.014744441712921745\ \(0\)\
\-\ confirm\\:\\ 0\\.014744441712921745\ \(0\)\
\-\ rapid\\:\\ 0\\.014629521198766891\ \(0\)\
\-\ invasive\\:\\ 0\\.014555016430228671\ \(0\)\
\-\ annual\\:\\ 0\\.01451836925699404\ \(0\)\
\-\ assess\\:\\ 0\\.01451836925699404\ \(0\)\
\-\ immediately\\:\\ 0\\.014375618459197001\ \(0\)\
\-\ higher\\:\\ 0\\.014205239358244836\ \(0\)\
\-\ discharge\\:\\ 0\\.014043015557642683\ \(0\)\
\-\ sonographic\\:\\ 0\\.014043015557642683\ \(0\)\
\-\ upper\\:\\ 0\\.013980206816059108\ \(0\)\
\-\ noted\\:\\ 0\\.013731669074254872\ \(0\)\
\-\ therefore\\:\\ 0\\.0136826946808643\ \(0\)\
\-\ associated\\:\\ 0\\.013670932623103064\ \(0\)\
\-\ remainder\\:\\ 0\\.013654327732828653\ \(0\)\
\-\ be\\:\\ 0\\.013400915830616228\ \(0\)\
\-\ included\\:\\ 0\\.013357020680560498\ \(0\)\
\-\ incidence\\:\\ 0\\.013280266522086734\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.01320521185809618\ \(0\)\
\-\ can\\:\\ 0\\.013140490525214031\ \(0\)\
\-\ circumscribed\\:\\ 0\\.012875385041191775\ \(0\)\
\-\ difficult\\:\\ 0\\.01267913426689041\ \(0\)\
\-\ either\\:\\ 0\\.012616163468338088\ \(0\)\
\-\ round\\:\\ 0\\.012513743879875387\ \(0\)\
\-\ screening\\:\\ 0\\.012356048911621514\ \(0\)\
\-\ absence\\:\\ 0\\.012043485542581738\ \(0\)\
\-\ related\\:\\ 0\\.011956784383972756\ \(0\)\
\-\ excision\\:\\ 0\\.011888985513780655\ \(0\)\
\-\ are\\:\\ 0\\.011846174974877305\ \(0\)\
\-\ reveals\\:\\ 0\\.011333043221339061\ \(0\)\
\-\ change\\:\\ 0\\.011290581323646926\ \(0\)\
\-\ skin\\:\\ 0\\.011125860797420265\ \(0\)\
\-\ confirmed\\:\\ 0\\.010892880010463719\ \(0\)\
\-\ very\\:\\ 0\\.010514527520193658\ \(0\)\
\-\ calcification\\:\\ 0\\.010514527520193658\ \(0\)\
\-\ malignant\\:\\ 0\\.010470070089421359\ \(0\)\
\-\ they\\:\\ 0\\.010437105513516292\ \(0\)\
\-\ otherwise\\:\\ 0\\.010404458418394389\ \(0\)\
\-\ biopsy\\:\\ 0\\.010276926242836475\ \(0\)\
\-\ quadrant\\:\\ 0\\.010194494691478151\ \(0\)\
\-\ to\\:\\ 0\\.010133819522375945\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.009791838637274872\ \(0\)\
\-\ although\\:\\ 0\\.009782811120598657\ \(0\)\
\-\ this\\:\\ 0\\.009774276745567453\ \(0\)\
\-\ type\\:\\ 0\\.00976482789270139\ \(0\)\
\-\ areas\\:\\ 0\\.009746939563545989\ \(0\)\
\-\ left\\:\\ 0\\.009723104433283877\ \(0\)\
\-\ often\\:\\ 0\\.009242283215320855\ \(0\)\
\-\ follow\\:\\ 0\\.009204066006598082\ \(0\)\
\-\ between\\:\\ 0\\.009181340800760149\ \(0\)\
\-\ area\\:\\ 0\\.009158766929268702\ \(0\)\
\-\ the\\:\\ 0\\.008904191218199627\ \(0\)\
\-\ usually\\:\\ 0\\.0087963669622602\ \(0\)\
\-\ evaluation\\:\\ 0\\.008414368799412908\ \(0\)\
\-\ changes\\:\\ 0\\.008301857546559528\ \(0\)\
\-\ two\\:\\ 0\\.008296038093613579\ \(0\)\
\-\ an\\:\\ 0\\.008011287215489693\ \(0\)\
\-\ at\\:\\ 0\\.007849241714112765\ \(0\)\
\-\ up\\:\\ 0\\.007789312376454994\ \(0\)\
\-\ for\\:\\ 0\\.007414659138739475\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.0071191018224807355\ \(0\)\
\-\ physical\\:\\ 0\\.0071067975240041974\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.006982201701634721\ \(0\)\
\-\ or\\:\\ 0\\.006789984738737\ \(0\)\
\-\ 3\\:\\ 0\\.006782967887140812\ \(0\)\
\-\ was\\:\\ 0\\.0067001865912792325\ \(0\)\
\-\ other\\:\\ 0\\.006676740843059147\ \(0\)\
\-\ small\\:\\ 0\\.006673136557224131\ \(0\)\
\-\ were\\:\\ 0\\.006577241819287869\ \(0\)\
\-\ well\\:\\ 0\\.00655281678972424\ \(0\)\
\-\ may\\:\\ 0\\.00635365548779025\ \(0\)\
\-\ treatment\\:\\ 0\\.005863108337630125\ \(0\)\
\-\ no\\:\\ 0\\.005833519665788488\ \(0\)\
\-\ patient\\:\\ 0\\.005807402921467037\ \(0\)\
\-\ seen\\:\\ 0\\.005724161407009119\ \(0\)\
\-\ also\\:\\ 0\\.005710574893797123\ \(0\)\
\-\ which\\:\\ 0\\.0054072697872628766\ \(0\)\
\-\ a\\:\\ 0\\.005377624431438661\ \(0\)\
\-\ and\\:\\ 0\\.004881600155449992\ \(0\)\
\-\ by\\:\\ 0\\.004823291197440253\ \(0\)\
\-\ \\,\\:\\ 0\\.0045883061952082605\ \(0\)\
\-\ as\\:\\ 0\\.004381618664047891\ \(0\)\
\-\ in\\:\\ 0\\.004285395560748355\ \(0\)\
\-\ of\\:\\ 0\\.003554353244684393\ \(0\)\
\-\ on\\:\\ 0\\.002453867838526875\ \(0\)\
\-\ \\.\\:\\ 0\\.002286410799490099\ \(0\)\
\-\ with\\:\\ 0\\.001586497302913759\ \(0\)\
